Recent studies show that the famous gene-editing tool does more in bacteria than just spot DNA for chopping up; it coordinates with other proteins to bulk up defenses against invading viruses as well.
Now scientists have used CRISPR to remove and add genes to these cells to help them recognize a patient’s specific tumor cells.
For the first time in the world, complete chromosomal rearrangement in mammals have been achieved, making a new breakthrough in synthetic biology.
Scientists think they have achieved the first gene editing inside the body, altering DNA in adults to try to treat a disease.
A Chinese researcher claims that he helped make the world's first genetically edited babies—twin girls born this month whose DNA he said he altered with a powerful new tool capable of rewriting the very blueprint of life.
Researchers have developed a new platform that makes CRISPR less like a cutting tool and more like a word processor with a search-and-replace function.
Editing another essential molecular component of our biology—RNA, the messenger used by cells to turns DNA instructions into proteins— holds great promise.
In the U.S., the first planned clinical trials of CRISPR gene editing in people are about to kick off. China already used the gene-altering tool to change the DNA of dozens of people in several clinical trials.
US scientists have edited the DNA inside of a patient’s body, in an attempt to cure a genetic disorder by permanently changing the human genome. The news represents a major landmark in science.
Scientists have, for the first time, corrected a disease-causing mutation in early stage human embryos with gene editing.
The data is unpublished, but scientists say it advances effort to erase genetic diseases.
A Food and Drug Administration panel has recommended approval of a leukemia treatment that rewires a patient’s immune cells to fight cancer.